Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-25-010978
Filing Date
2025-03-20
Accepted
2025-03-20 07:30:47
Documents
96
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1949892
2 ex19.htm EX-19 69135
3 ex21.htm EX-21 2389
4 ex23-1.htm EX-23.1 3454
5 ex31-1.htm EX-31.1 19427
6 ex31-2.htm EX-31.2 20030
7 ex32.htm EX-32 12679
8 ex97.htm EX-97 65478
  Complete submission text file 0001493152-25-010978.txt   9228482

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE abeo-20241231.xsd EX-101.SCH 59590
10 XBRL CALCULATION FILE abeo-20241231_cal.xml EX-101.CAL 84532
11 XBRL DEFINITION FILE abeo-20241231_def.xml EX-101.DEF 258675
12 XBRL LABEL FILE abeo-20241231_lab.xml EX-101.LAB 557675
13 XBRL PRESENTATION FILE abeo-20241231_pre.xml EX-101.PRE 453408
98 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1340699
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 25754504
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)